Search Results for: "National Institute on Drug Abuse"

HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus

NIH logo

NIH-Funded Trial Proves Suppressive Antiretroviral Therapy for HIV-infected People Effective in Protecting Uninfected Partners ​Antiretroviral treatment that consistently suppresses HIV is highly effective at preventing sexual transmission of the virus in heterosexual couples where one person is HIV-infected and the other is not, investigators report today at the 8th International AIDS Society Conference on HIV…

NIH Funding Opportunity for Drug Abuse Prevention Research Holds Potential for Addressing Viral Hepatitis

Ronald Valdiserri

The National Institute on Drug Abuse (NIDA), part of NIH, has released a Funding Opportunity Announcement (FOA) for research that will increase understanding of the science of drug use prevention within diverse populations and settings. Given the high prevalence of hepatitis C virus (HCV) infection among persons who inject drugs (PWID), this research also holds…

Advancing the Viral Hepatitis Action Plan: Checking-In with Federal and Community Leaders

VHIG Oct 2014-035

On Tuesday, 10/14/14, the cross-government working group supporting and monitoring the implementation of the updated Viral Hepatitis Action Plan—the Viral Hepatitis Implementation Group or “VHIG”—met in Washington, DC to share updates on 2014 accomplishments and plans for the coming year. Some of the highlights included: Promising preliminary data from HRSA’s Bureau of Primary Health Care…

NIH Seeks Applications for HIV and Viral Hepatitis Co-Infection Research Funding

Ronald Valdiserri

The National Institutes of Health (NIH) recently released two funding opportunity announcements (FOAs) to support multidisciplinary studies of HIV and viral hepatitis co-infection. The opportunities were issued under NIH’s R01 or Research Project Grant program and R21 or Exploratory/Developmental Research Grant program. NIH notes that the FOAs were informed by priority areas in the Action…

NIDA 2014 Avant-Garde Award for HIV/AIDS Research

NIDA arp

This week, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced the 2014 Avant-Garde Awards for HIV/AIDS research. According to a NIDA press release, the awards offer hope in battling HIV infection and improving long-term outcomes in HIV-infected drug users. With proposals ranging from enhancing the immune system’s ability…

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

Together on the Pathways to Wellness: Recovery and Efforts to Strengthen Viral Hepatitis Services

Ronald Valdiserri

Throughout September’s observance of National Recovery Month, individuals, organizations, and communities across the nation celebrated recovery from mental health issues and addiction challenges. Given the significant role that drug-using behaviors can play in the transmission of viral hepatitis, and the fact that alcohol intake often worsens liver disease among persons with chronic viral hepatitis, National Recovery…

NIH Observes 20th Anniversary of Women’s Interagency HIV Study


The largest and longest-running study to investigate the impact of HIV on women in the United States marks its 20th anniversary this month. Findings from the Women’s Interagency HIV Study (WIHS) have helped define how best to treat HIV-infected women in the United States and globally. The National Institute of Allergy and Infectious Diseases (NIAID),…